Volume 130, Issue 9 pp. 1120-1127
RESEARCH ARTICLE

Symptoms of postural orthostatic tachycardia syndrome in pregnancy: a cross-sectional, community-based survey

Kate M. Bourne

Kate M. Bourne

Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
Kara A. Nerenberg

Kara A. Nerenberg

Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada

Department of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
Lauren E. Stiles

Lauren E. Stiles

Stony Brook University School of Medicine, Stony Brook, New York, USA

Dysautonomia International, East Moriches, New York, USA

Search for more papers by this author
Cyndya A. Shibao

Cyndya A. Shibao

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for more papers by this author
Luis E. Okamoto

Luis E. Okamoto

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for more papers by this author
Emily M. Garland

Emily M. Garland

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for more papers by this author
Alfredo Gamboa

Alfredo Gamboa

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for more papers by this author
Amanda Peltier

Amanda Peltier

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for more papers by this author
André Diedrich

André Diedrich

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for more papers by this author
Italo Biaggioni

Italo Biaggioni

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for more papers by this author
Robert S. Sheldon

Robert S. Sheldon

Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
Paul S. Gibson

Paul S. Gibson

Department of Medicine, University of Calgary, Calgary, Alberta, Canada

Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
Angela J. Kealey

Angela J. Kealey

Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
Satish R. Raj

Corresponding Author

Satish R. Raj

Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada

Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Correspondence

Satish R. Raj, HRIC GAC70, 3280 Hospital Dr NW, Calgary, AB T2N 4Z6, Canada.

Email: [email protected]

Search for more papers by this author
First published: 22 February 2023
Citations: 1

This article includes Author Insights, a video abstract available at: https://players.brightcove.net/3806881048001/default_default/index.html?videoId=6319977749112

Abstract

Objective

To evaluate the relationship between postural orthostatic tachycardia syndrome (POTS) and pregnancy.

Design

Cross-sectional survey.

Setting

International.

Sample

A total of 8941 female patients with a diagnosis of POTS.

Methods

Data from the survey were analysed using descriptive measures and stratified for comparisons.

Main outcome measures

Symptom course of POTS during pregnancy. Secondary outcomes included pregnancy loss, POTS onset during pregnancy and the impacts of a comorbid diagnosis of Ehlers–Danlos syndrome or an autoimmune disorder on symptoms during pregnancy.

Results

Overall, 40.8% (n = 3652) of participants reported one or more pregnancies. Most participants experienced worsening of symptoms in the first (62.6%) and third (58.9%) trimesters and 3 months after pregnancy (58.7%), and 81.1% experienced worsening symptoms at any point in their pregnancy. Most participants with worsening symptoms in the first trimester also experienced worsening symptoms in the second (61.6%) and third (68.1%) trimesters, but if they improved in the first trimester then this improvement persisted in the second and third trimesters. Of participants who reported that POTS was triggered by a specific event (41.3%), 8.1% reported pregnancy as the trigger for the onset.

Conclusions

Postural orthostatic tachycardia syndrome symptoms in the first trimester of pregnancy may help predict symptom course throughout the duration of pregnancy. Some individuals may experience an initial onset of POTS during pregnancy. This novel information may guide clinicians in counselling patients with POTS who are planning pregnancy.

CONFLICT OF INTERESTS STATEMENT

KMB, KAN, LES, CAS, LEO, EMG, AG, AD, AJK and PSG, have no conflicts of interest to report. AP is a consultant for Alnylam, Catalyst, and Argenx. IB is a consultant for Theravance Biopharma Inc., Ammeal Pharmaceuticals, Regeneron, and Takeda Pharmaceutical. RSS is a Cardiac Arrhythmia Network of Canada (CANet) Network Investigator. SRR is a consultant for Lundbeck NA Ltd.Theravance Biopharma Inc., Amneal Pharma, Servier Affaires Medicales, Regeneron, and argenx BV, is the chair for the Data Safety and Monitoring Board for Arena Pharmaceuticals, is a CANet Network Investigator, and is a member of the Medical Advisory Board of Dysautonomia International and PoTS UK, both without financial compensation. Completed disclosure of interests form available to view online as supporting information.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available in the supporting information for this article.